These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16606943)

  • 1. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
    Khan OA
    Neurology; 2006 Apr; 66(7):1131-2; author reply 1131-2. PubMed ID: 16606943
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
    Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
    Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.
    Garbern JY
    J Neurol Sci; 2005 Feb; 228(2):201-3. PubMed ID: 15694206
    [No Abstract]   [Full Text] [Related]  

  • 4. Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype.
    Plecko B; Stöckler-Ipsiroglu S; Gruber S; Mlynarik V; Moser E; Simbrunner J; Ebner F; Bernert G; Harrer G; Gal A; Prayer D
    Neuropediatrics; 2003 Jun; 34(3):127-36. PubMed ID: 12910435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PLP mutants from mouse to man.
    Duncan ID
    J Neurol Sci; 2005 Feb; 228(2):204-5. PubMed ID: 15694207
    [No Abstract]   [Full Text] [Related]  

  • 6. Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.
    Vaurs-Barrière C; Deville M; Sarret C; Giraud G; Des Portes V; Prats-Viñas JM; De Michele G; Dan B; Brady AF; Boespflug-Tanguy O; Touraine R
    Ann Neurol; 2009 Jan; 65(1):114-8. PubMed ID: 19194886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin mishaps.
    Barkovich AJ
    Ann Neurol; 2007 Aug; 62(2):107-9. PubMed ID: 17683086
    [No Abstract]   [Full Text] [Related]  

  • 8. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
    McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
    Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelination of a fetus with Pelizaeus-Merzbacher disease: immunopathological study.
    Shiraishi K; Itoh M; Sano K; Takashima S; Kubota T
    Ann Neurol; 2003 Aug; 54(2):259-62. PubMed ID: 12891682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease.
    Fattal-Valevski A; DiMaio MS; Hisama FM; Hobson GM; Davis-Williams A; Garbern JY; Mahoney MJ; Kolodny EH; Pastores GM
    J Child Neurol; 2009 May; 24(5):618-24. PubMed ID: 19151366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the natural history of Pelizaeus-Merzbacher disease.
    Mayer JA; Griffiths IR; Goldman JE; Smith CM; Cooksey E; Radcliff AB; Duncan ID
    Neurobiol Dis; 2015 Mar; 75():115-30. PubMed ID: 25562656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelizaeus Merzbacher disease: dysmyelination versus demyelination.
    Akinaga K; Lee TY; Montenegro MA
    Arq Neuropsiquiatr; 2016 Jan; 74(1):81. PubMed ID: 26486495
    [No Abstract]   [Full Text] [Related]  

  • 13. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted SOX10 regulation of GJC2 transcription causes Pelizaeus-Merzbacher-like disease.
    Osaka H; Hamanoue H; Yamamoto R; Nezu A; Sasaki M; Saitsu H; Kurosawa K; Shimbo H; Matsumoto N; Inoue K
    Ann Neurol; 2010 Aug; 68(2):250-4. PubMed ID: 20695017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A de novo TUBB4A mutation in a patient with hypomyelination mimicking Pelizaeus-Merzbacher disease.
    Shimojima K; Okumura A; Ikeno M; Nishimura A; Saito A; Saitsu H; Matsumoto N; Yamamoto T
    Brain Dev; 2015 Mar; 37(3):281-5. PubMed ID: 24974158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
    Takanashi J
    Magn Reson Med Sci; 2015; 14(2):85-91. PubMed ID: 26185828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic hypertrophy in dysmyelination influences the diffusion anisotropy of white matter.
    Harsan LA; Poulet P; Guignard B; Parizel N; Skoff RP; Ghandour MS
    J Neurosci Res; 2007 Apr; 85(5):935-44. PubMed ID: 17278151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton MR spectroscopy in connatal Pelizaeus-Merzbacher disease.
    Spalice A; Popolizio T; Parisi P; Scarabino T; Iannetti P
    Pediatr Radiol; 2000 Mar; 30(3):171-5. PubMed ID: 10755756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelizaeus-Merzbacher Disease: A Caregiver Assessment of Disease Impact.
    Moore KM; Wolf NI; Hobson G; Bowyer K; McSherry J; Hartin G; Wilde C; Shapiro S; Frank J; Manley D; Junge C
    J Child Neurol; 2023 Feb; 38(1-2):78-84. PubMed ID: 36744386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Duplication of the PLP gene and the classical form of Pelizaeus-Merzbacher disease].
    Blanco-Barca MO; Eirís-Puñal J; Soler-Regal C; Castro-Gago M
    Rev Neurol; 2003 Sep 1-15; 37(5):436-8. PubMed ID: 14533091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.